Jessica Gates is an accomplished Senior Manager of Oncology Omnichannel Marketing at Myriad Genetics, where she leverages her extensive expertise in marketing strategy and customer engagement to drive impactful initiatives within the oncology business unit. With a strong foundation in voice of customer (VOC) insights...
Jessica Gates is an accomplished Senior Manager of Oncology Omnichannel Marketing at Myriad Genetics, where she leverages her extensive expertise in marketing strategy and customer engagement to drive impactful initiatives within the oncology business unit. With a strong foundation in voice of customer (VOC) insights and market development, Jessica excels in understanding the nuanced needs and behaviors of healthcare professionals and patients alike. This deep understanding informs her approach to developing and executing comprehensive marketing strategies that seamlessly integrate digital platforms, paid and earned media, events, and sales support.
In her current role, Jessica leads a dynamic omnichannel marketing team, focusing on delivering consistent and compelling messaging that resonates across all customer touchpoints. She is instrumental in orchestrating new product launches, ensuring that each initiative is backed by robust evidence generation and market validation. Her leadership extends to cross-functional collaboration, where she works closely with product development, sales, and medical affairs teams to align marketing strategies with overarching business goals.
Key projects under Jessica’s stewardship include the launch of innovative oncology diagnostics that empower healthcare providers with critical insights for patient care. By employing a go-to-market strategy that emphasizes value propositions and customer-centric messaging, she has successfully increased brand awareness and engagement within the oncology community. Jessica’s strategic leadership and commitment to excellence position her as a pivotal force in advancing Myriad Genetics' mission to transform patient outcomes through precision medicine.
